Review of new immunomodulatory agents in the treatment of multiple sclerosis

被引：0
|
作者：
O'Connor, PW [1 ]
机构：
[1] St Michaels Hosp, Toronto, ON M5B 1W8, Canada
来源：
MULTIPLE SCLEROSIS | 2005年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S12 / S12
页数：1
相关论文
共 50 条
  • [41] Immunomodulatory Agents for Multiple Myeloma
    Minarik, Jiri
    Sevcikova, Sabina
    CANCERS, 2022, 14 (23)
  • [42] Something Old, New, Borrowed, Blue: Anthracenedione Agents for Treatment of Multiple Sclerosis
    Koffman, Boyd M.
    Hacker, Miles
    Gunning, William T.
    Quinn, Anthony
    CLINICAL NEUROPHARMACOLOGY, 2016, 39 (02) : 102 - 111
  • [43] Systematic review of immunomodulatory drugs for the treatment of people with multiple sclerosis: Is there good quality evidence on effectiveness and cost?
    Bryant, J
    Clegg, A
    Milne, R
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2001, 70 (05): : 574 - 579
  • [44] Consensus statement of the SEP Canadian Network clinics on: the use of immunomodulatory agents in multiple sclerosis
    O'Connor, Paul
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2008, 35 (02) : 130 - 132
  • [45] Clinical characteristics of multiple sclerosis patients undergoing immunomodulatory treatment in Poland
    Kulakowska, A.
    Wawrzyniak, S.
    Koziarska, D.
    Adamczyk-Sowa, M.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E309 - E310
  • [46] Turning Mechanistic Immunomodulatory insights into personalized treatment strategies for multiple sclerosis
    Ntranos, Achilles
    Sand, Ilana Katz
    Casaccia, Patrizia
    NEUROLOGY, 2019, 92 (15)
  • [47] Immunomodulatory characteristics of mesenchymal stem cells and their role in the treatment of Multiple Sclerosis
    Gharibi, Tohid
    Ahmadi, Majid
    Seyfizadeh, Narges
    Jadidi-Niaragh, Farhad
    Yousefi, Mehdi
    CELLULAR IMMUNOLOGY, 2015, 293 (02) : 113 - 121
  • [48] The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis
    Warrender-Sparkes, Matthew
    Spelman, Tim
    Izquierdo, Guillermo
    Trojano, Maria
    Lugaresi, Alessandra
    Grand'Maison, Francois
    Havrdova, Eva
    Horakova, Dana
    Boz, Cavit
    Oreja-Guevara, Celia
    Alroughani, Raed
    Iuliano, Gerardo
    Duquette, Pierre
    Girard, Marc
    Terzi, Murat
    Hupperts, Raymond
    Grammond, Pierre
    Petersen, Thor
    Fernandez-Bolanos, Ricardo
    Fiol, Marcela
    Pucci, Eugenio
    Lechner-Scott, Jeannette
    Verheul, Freek
    Cristiano, Edgardo
    Van Pesch, Vincent
    Petkovska-Boskova, Tatjana
    Moore, Fraser
    Kister, Ilya
    Bergamaschi, Roberto
    Laura Saladino, Maria
    Slee, Mark
    Barnett, Michael
    Amato, Maria Pia
    Shaw, Cameron
    Shuey, Neil
    Young, Carolyn
    Gray, Orla
    Kappos, Ludwig
    Butzkueven, Helmut
    Kalincik, Tomas
    Jokubaitis, Vilija
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (04) : 520 - 532
  • [49] Comparison of immunomodulatory therapies in treatment of relapsing-remitting multiple sclerosis
    Aydin Canturk, I.
    Isik, N.
    Unsal, A.
    Arici, O.
    Yildiz, N.
    Candan, F.
    MULTIPLE SCLEROSIS, 2006, 12 : S96 - S96
  • [50] Laquinimod, an up-and-coming immunomodulatory agent for treatment of multiple sclerosis
    Varrin-Doyer, Michel
    Zamvil, Scott S.
    Schulze-Topphoff, Ulf
    EXPERIMENTAL NEUROLOGY, 2014, 262 : 66 - 71
12345